Xtant Medical Holdings (XTNT:NYSE) Annual Reports & Investor Relations Material

Overview

Xtant Medical Holdings, Inc., a regenerative medicine products and medical devices manufacturer, operates in the United States and international markets for neurological and orthopedic surgery. The firm's products, including OsteoSponge, OsteoSelect DBM Putty, OsteoSelect PLUS DBM Putty, OsteoFactor, and OsteoVive Plus, among others, use natural scaffolding for cellular in-growth and expose bone-forming proteins to the healing environment. The company also offers allografts with osteoinductive potential and processes sports allografts for ACL and meniscal repair, and milled spinal allografts. Furthermore, the firm provides spinal fixation, interspinous fusion, and minimally invasive pedicle screw systems, such as the Spider cervical plating, Axle interspinous fusion, and Xpress pedicle screw. Xtant Medical Holdings, Inc. was previously known as Bacterin International Holdings, Inc., and its headquarters is located in Belgrade, Montana.

Frequently Asked Questions

What is Xtant Medical Holdings's ticker?

Xtant Medical Holdings's ticker is XTNT

What exchange is Xtant Medical Holdings traded on?

The company's shares trade on the NYSE stock exchange

Where are Xtant Medical Holdings's headquarters?

They are based in Belgrade, Montana

How many employees does Xtant Medical Holdings have?

There are 201-500 employees working at Xtant Medical Holdings

What is Xtant Medical Holdings's website?

It is xtantmedical.com

What type of sector is Xtant Medical Holdings?

Xtant Medical Holdings is in the Healthcare sector

What type of industry is Xtant Medical Holdings?

Xtant Medical Holdings is in the Biotechnology industry

Who are Xtant Medical Holdings's peers and competitors?

The following five companies are Xtant Medical Holdings's industry peers:

- Allogene Therapeutics

- CytoDyn Inc

- Salarius Pharmaceuticals

- Recro Pharma

- AnPac Bio-Medical Science Co., Ltd.